The fact
These pressures raise questions about ethics and independence in French health decision-making.
The HAS calls for heightened vigilance against pharmaceutical industry lobbying practices.
Click the link to read an article on the topic:
These pressures raise questions about ethics and independence in French health decision-making.
The HAS calls for heightened vigilance against pharmaceutical industry lobbying practices.